Triomune 30+150+200mg is a pharmaceutical formulation that stands at the forefront of modern medical science, specifically crafted to provide effective treatment for individuals dealing with HIV/AIDS. This medication embodies a synergistic combination of active ingredients designed to combat the human immunodeficiency virus (HIV) and support the immune system in its battle against acquired immunodeficiency syndrome (AIDS).
HIV & Herpes
Triomune 30+150+200mg Tablets
Generic Name Stavudine+Lamivudine+Nevirapine
Add to WishlistRemove from Wishlist
Add to Wishlist
Ingredients
Each Triomune 30+150+200mg tablet contains a triple combination of antiretroviral drugs, namely Stavudine (30mg), Lamivudine (150mg), and Nevirapine (200mg). This powerful trio works collectively to inhibit the replication of the HIV virus, preventing its spread within the body. Stavudine and Lamivudine belong to the nucleoside reverse transcriptase inhibitor (NRTI) class, while Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Product
Triomune 30+150+200mg plays a crucial role in managing HIV/AIDS by suppressing viral activity and maintaining or restoring the immune system’s functionality. The combination of these antiretroviral agents impedes the virus’s ability to replicate, reducing the viral load and allowing the immune system to recover. This comprehensive approach contributes to the long-term control of HIV infection and the prevention of AIDS-related complications.
Usage
It is imperative to strictly adhere to the prescribed guidelines for Triomune 30+150+200mg usage. These tablets are typically taken orally with or without food, as directed by a healthcare professional. Compliance with the prescribed regimen is crucial for the medication’s efficacy and to minimize the risk of developing drug resistance. Patients are advised to consult their healthcare provider for personalized dosing instructions and any potential interactions with other medications.
Manufacturer
Triomune 30+150+200mg Tablets are manufactured by Cipla Ltd., a reputable pharmaceutical company committed to maintaining high-quality standards. Cipla’s dedication to producing reliable and effective medications underscores the importance of Triomune in the management of HIV/AIDS.
In summary, Triomune 30+150+200mg Tablets offer a robust therapeutic solution for individuals grappling with HIV/AIDS. The combined action of Stavudine, Lamivudine, and Nevirapine targets the virus at different stages of its life cycle, providing a comprehensive approach to antiretroviral therapy. As with any medication, it is essential to consult a healthcare professional for personalized advice and guidance on the proper use of Triomune 30+150+200mg.
Reviews
There are no reviews yet.